Sivik Global Healthcare’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-70,000
| Closed | -$3.96M | – | 36 |
|
|
2024
Q4 | $3.96M | Buy |
+70,000
| New | +$3.91M | 2.08% | 24 |
|
|
2022
Q1 | – | Sell |
-70,000
| Closed | -$4.37M | – | 51 |
|
|
2021
Q4 | $4.37M | Buy |
+70,000
| New | +$4.11M | 1.87% | 26 |
|
|
2021
Q3 | – | Sell |
-85,000
| Closed | -$5.68M | – | 48 |
|
|
2021
Q2 | $5.68M | Buy |
+85,000
| New | +$5.54M | 1.11% | 28 |
|
|
2020
Q3 | – | Sell |
-60,000
| Closed | -$3.81M | – | 45 |
|
|
2020
Q2 | $3.81M | Sell |
60,000
-260,000
| -81% | -$15.6M | 1.26% | 38 |
|
|
2020
Q1 | $18.5M | Buy |
320,000
+190,000
| +146% | +$11.6M | 7.29% | 1 |
|
|
2019
Q4 | $8.35M | Buy |
+130,000
| New | +$7.45M | 3.1% | 4 |
|
|
2018
Q4 | – | Sell |
-140,000
| Closed | -$8.69M | – | 51 |
|
|
2018
Q3 | $8.69M | Buy |
140,000
+5,000
| +4% | +$297K | 3.1% | 3 |
|
|
2018
Q2 | $7.47M | Buy |
135,000
+55,000
| +69% | +$2.97M | 2.87% | 4 |
|
|
2018
Q1 | $5.06M | Buy |
80,000
+5,000
| +7% | +$322K | 2.36% | 14 |
|
|
2017
Q4 | $4.6M | Buy |
+75,000
| New | +$4.69M | 1.71% | 27 |
|
|
2017
Q2 | – | Sell |
-77,400
| Closed | -$4.21M | – | 69 |
|
|
2017
Q1 | $4.21M | Sell |
77,400
-47,600
| -38% | -$2.61M | 1.96% | 25 |
|
|
2016
Q4 | $7.3M | Buy |
+125,000
| New | +$6.83M | 3.49% | 7 |
|
|
2016
Q3 | – | Sell |
-55,000
| Closed | -$4.04M | – | 50 |
|
|
2016
Q2 | $4.04M | Sell |
55,000
-25,000
| -31% | -$1.77M | 2.01% | 20 |
|
|
2016
Q1 | $5.11M | Buy |
80,000
+5,000
| +7% | +$315K | 2.26% | 17 |
|
|
2015
Q4 | $5.16M | Hold |
75,000
| – | – | 2.45% | 12 |
|
|
2015
Q3 | $4.44M | Buy |
75,000
+5,500
| +8% | +$349K | 2.15% | 20 |
|
|
2015
Q2 | $4.63M | Buy |
69,500
+2,000
| +3% | +$132K | 1.6% | 22 |
|
|
2015
Q1 | $4.35M | Sell |
67,500
-11,700
| -15% | -$732K | 1.48% | 30 |
|
|
2014
Q4 | $4.67M | Buy |
79,200
+9,200
| +13% | +$519K | 1.89% | 20 |
|
|
2014
Q3 | $3.58M | Buy |
70,000
+10,000
| +17% | +$500K | 1.63% | 25 |
|
|
2014
Q2 | $2.91M | Sell |
60,000
-22,780
| -28% | -$1.12M | 1.47% | 29 |
|
|
2014
Q1 | $4.3M | Buy |
82,780
+7,780
| +10% | +$414K | 2.68% | 6 |
|
|
2013
Q4 | $3.99M | Buy |
+75,000
| New | +$3.82M | 2.83% | 7 |
|
Other funds holding BMY
Sivik Global Healthcare's BMY Position: Q1 2025 in Review
Sivik Global Healthcare sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 70,000 shares — an estimated $3.96M sold.
Sivik Global Healthcare first reported a position in BMY in Q4 2013 and held it in 23 quarters. The position peaked at $18.5M in Q1 2020. 2,477 funds tracked by Wall St. Rank hold BMY as of Q1 2025.
- Sivik Global Healthcare reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
- Sivik Global Healthcare sold 70,000 Bristol-Myers Squibb shares in Q1 2025, an estimated $3.96M.
- Sivik Global Healthcare first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 23 quarters.
- Sivik Global Healthcare's Bristol-Myers Squibb position peaked at $18.5M in Q1 2020.
- 2,477 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.
Based on Sivik Global Healthcare's 13F filing for Q1 2025, filed 22 Apr 2025.